Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy.

Mathupala SP, Ko YH, Pedersen PL

Open source

DOI
10.1016/j.semcancer.2008.11.006
Published
2009 Feb
Container
Seminars in cancer biology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.semcancer.2008.11.006,
  title = {Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy.},
  author = {Mathupala SP and Ko YH and Pedersen PL},
  year = {2009},
  journal = {Seminars in cancer biology},
  doi = {10.1016/j.semcancer.2008.11.006},
  url = {https://doi.org/10.1016/j.semcancer.2008.11.006}
}

RIS

TY  - JOUR
TI  - Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy.
AU  - Mathupala SP
AU  - Ko YH
AU  - Pedersen PL
PY  - 2009
JO  - Seminars in cancer biology
DO  - 10.1016/j.semcancer.2008.11.006
UR  - https://doi.org/10.1016/j.semcancer.2008.11.006
ER  - 

APA

SP, M., YH, K., & PL, P. (2009). Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy.. Seminars in cancer biology. https://doi.org/10.1016/j.semcancer.2008.11.006

Source records